-
Loading metrics
Open Access
Peer-reviewed
Research Article
Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan
-
Tomohiro Koga ,
* E-mail: tkoga@nagasaki-u.ac.jp
Affiliations Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan, Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan
⨯ -
Akitomo Okada,
Affiliation Japanese Red Cross Nagasaki Genbaku Hospital, Department of Rheumatology, Mori-machi 3–15, Nagasaki, Japan
⨯ -
Takaaki Fukuda,
Affiliation Kurume University Medical Center, Department of Rheumatology, Kokubun 155–1, Kurume, Japan
⨯ -
Toshihiko Hidaka,
Affiliation Zenjinkai Shimin-no-Mori Hospital, Shioji 2783–37, Miyazaki, Japan
⨯ -
Tomonori Ishii,
Affiliation Tohoku University Hospital, Department of Hematology and Rheumatology, Aoba-ku, seiryo 1–1, Sendai, Japan
⨯ -
Yukitaka Ueki,
Affiliation Sasebo Chuo Hospital, Rheumatic and Collagen Disease Center, Yamato 15, Sasebo, Japan
⨯ -
Takao Kodera,
Affiliation Tohoku Medical and Pharmaceutical University Hospital, Aoba-ku, komatsujima 4-4-1, Sendai, Japan
⨯ -
Munetoshi Nakashima,
Affiliations Japanese Red Cross Nagasaki Genbaku Hospital, Department of Rheumatology, Mori-machi 3–15, Nagasaki, Japan, Kurume University Medical Center, Department of Rheumatology, Kokubun 155–1, Kurume, Japan
⨯ -
Yuichi Takahashi,
Affiliation Yu Family Clinic, Rifu-aza sinkan 2–5, Miyagi, Japan
⨯ -
Seiyo Honda,
Affiliation Kurume University School of Medicine, asahi-machi 67, Kurume, Japan
⨯ -
Yoshiro Horai,
Affiliation Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan
⨯ -
Ryu Watanabe,
Affiliation Tohoku University Hospital, Department of Hematology and Rheumatology, Aoba-ku, seiryo 1–1, Sendai, Japan
⨯ -
Hiroshi Okuno,
Affiliation Tohoku University Hospital, Department of Orthopaedic Surgery, Hirase 9–3, Sasebo, Japan
⨯ -
Toshiyuki Aramaki,
Affiliations Japanese Red Cross Nagasaki Genbaku Hospital, Department of Rheumatology, Mori-machi 3–15, Nagasaki, Japan, Sasebo Chuo Hospital, Rheumatic and Collagen Disease Center, Yamato 15, Sasebo, Japan
⨯ -
Tomomasa Izumiyama,
Affiliation East Sendai Rheumatism and internal medicine Clinic, Miyagino, Nittahigashi 1-17-5, Sendai, Japan
⨯ -
Osamu Takai,
Affiliation Osaki Citizen Hospital, Furukawa-honami 3-8-1, Osaki, Japan
⨯ -
Taiichiro Miyashita,
Affiliation NHO Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki Japan
⨯ -
Shuntaro Sato,
Affiliation Clinical Research Center, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan
⨯ -
Shin-ya Kawashiri,
Affiliations Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan, Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-12-4, Nagasaki, Japan
⨯ -
Naoki Iwamoto,
Affiliation Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan
⨯ -
Kunihiro Ichinose,
Affiliation Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan
⨯ -
Mami Tamai,
Affiliation Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan
⨯ -
Tomoki Origuchi,
Affiliation Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-12-4, Nagasaki, Japan
⨯ -
Hideki Nakamura,
Affiliation Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan
⨯ -
Kiyoshi Aoyagi,
Affiliation Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-12-4, Nagasaki, Japan
⨯ -
Katsumi Eguchi,
Affiliation Sasebo City General Hospital, Hirase 9–3, Sasebo, Japan
⨯ -
Atsushi Kawakami,
Affiliation Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki, Japan
⨯ - [ ... ],
-
the Japanese RA Patients with RRP Study Group
¶The complete membership of the author group can be found in the Acknowledgments.
⨯ - [ view all ]
- [ view less ]
Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan
- Tomohiro Koga,
- Akitomo Okada,
- Takaaki Fukuda,
- Toshihiko Hidaka,
- Tomonori Ishii,
- Yukitaka Ueki,
- Takao Kodera,
- Munetoshi Nakashima,
- Yuichi Takahashi,
- Seiyo Honda
- Published: May 15, 2017
- https://doi.org/10.1371/journal.pone.0175281